OZALIN

This brand name is authorized in Finland, France, Ireland, UK.

Active ingredients

The drug OZALIN contains one active pharmaceutical ingredient (API):

1	Midazolam UNII R60L0SM5BC - MIDAZOLAM
	Midazolam is a derivative of the imidazobenzodiazepine group. The free base is a lipophilic substance with low solubility in water. The basic nitrogen in position 2 of the imidazobenzodiazepine ring system enables the active ingredient of midazolam to form water-soluble salts with acids.
	Read more about Midazolam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OZALIN Oral solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CD08	Midazolam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	432389
FR	Base de données publique des médicaments	62149015
GB	Medicines & Healthcare Products Regulatory Agency	376014